J9144 – Injection, daratumumab, 10 mg and hyaluronidase-fihj
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9144
- Long description
- Injection, daratumumab, 10 mg and hyaluronidase-fihj
- Short description
- Daratumumab, hyaluronidase
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2021
- Last change
- January 1, 2021 – No change
Frequently asked questions
What is HCPCS code J9144?
J9144 is a HCPCS Level II code for injection, daratumumab, 10 mg and hyaluronidase-fihj.
Does Medicare cover J9144?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9075 – Injection, cyclophosphamide, not otherwise specified, 5 mg
- J9076 – Injection, cyclophosphamide (baxter), 5 mg
- J9098 – Injection, cytarabine liposome, 10 mg
- J9100 – Injection, cytarabine, 100 mg
- J9118 – Injection, calaspargase pegol-mknl, 10 units
- J9119 – Injection, cemiplimab-rwlc, 1 mg
- J9120 – Injection, dactinomycin, 0.5 mg
- J9130 – Dacarbazine, 100 mg
- J9145 – Injection, daratumumab, 10 mg
- J9150 – Injection, daunorubicin, 10 mg
- J9151 – Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 – Injection, degarelix, 1 mg
- J9160 – Injection, denileukin diftitox, 300 micrograms
- J9161 – Injection, denileukin diftitox-cxdl, 1 mcg
- J9165 – Injection, diethylstilbestrol diphosphate, 250 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.